use of a polynucleotide encoding or a polypeptide comprising at least the extracellular ipt - 3 and ipt - 4 domains of hepatocyte growth factor receptor for the screening and / or development of pharmacologically active agents useful in the treatment of cancer , preferably a cancer with dysregulation of hepatocyte growth factor receptor .